Market capitalization | $29.75m |
Enterprise Value | $-42.72m |
PER (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 0.94 |
EV/Sales (TTM) EV/Sales | -1.85 |
P/S ratio (TTM) P/S ratio | 1.29 |
P/B ratio (TTM) P/B ratio | 0.28 |
Sales growth (TTM) Sales growth | 28.25% |
Turnover (TTM) Turnover | $23.10m |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
3 Analysts have issued a Rapid Micro Biosystems Inc - Ordinary Shares - Class A forecast:
3 Analysts have issued a Rapid Micro Biosystems Inc - Ordinary Shares - Class A forecast:
Mar '24 |
+/-
%
|
||
Turnover | 23 23 |
28%
28%
|
|
Gross income | -5.22 -5.22 |
38%
38%
|
|
EBITDA | -52 -52 |
11%
11%
|
EBIT (operating result) EBIT | -56 -56 |
11%
11%
|
Net profit | -52 -52 |
13%
13%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. It provides mission critical automation solutions to facilitate the efficient manufacturing and safe release of healthcare products such as biologics, vaccines, cell & gene therapies, and sterile injectable. The company was founded by Donald Straus in 2006 and is headquartered in Lowell, MA.
Head office | United States |
CEO | Robert Spignesi |
Employees | 193 |
Founded | 2006 |
Website | www.rapidmicrobio.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.